Fact CheckerSign in

NCT07061171Completed

CPAP and Physiotherapy for Heart Failure and Sleep Apnea in the Elderly

The Impact of Continuous Positive Airway Pressure Combined With Physiotherapy on Ejection Fraction by Ameliorating Sleep Disturbance and Hypoxemia in Elderly Patients With Chronic Heart Failure and Obstructive Sleep Apnea: A Randomized Clinical Trial

Source: ClinicalTrials.gov · Last updated 11 Jul 2025

Brief summary (registry, in English)

This study evaluates whether adding physiotherapy (including herbal medicine, acupuncture, and Tuina massage) to standard continuous positive airway pressure (CPAP) therapy can provide superior benefits compared to CPAP alone for elderly patients suffering from both chronic heart failure (CHF) and obstructive sleep apnea (OSA). This randomized controlled trial aims to determine the combined therapy's efficacy and safety in improving sleep quality, hypoxemia, and cardiac function.

Status (registry)
Completed
Study type
Interventional
Enrollment
170 (actual)
First submitted
2 Jul 2025
Start date
1 Jan 2024
Primary completion date
1 Jan 2025
Lead sponsor
Weihua Peng
NCT number
NCT07061171

What you commit to

  • Study type: Interventional
  • Participants enrolled: 170
  • From 1 Jan 2024 to the primary completion date, 1 Jan 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Received related treatment for OSA or significant changes in CHF medication within the past month.
  • Current participation in other clinical drug trials.

Other illness

  • Secondary hypertension.
  • Acute myocardial infarction, congenital heart disease, rapid arrhythmias, significant valvular heart disease, cardiomyopathy, or severe hepatic/renal insufficiency.
  • Other respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, or pulmonary hypertension.
  • Use of sedative drugs, morphine or its analogues, or other psychotropic medications; cognitive impairment.

Other

  • Withdrawal from the study midway.

Who the study is looking for

  • Diagnosis of CHF according to the New York Heart Association (NYHA) functional classification II-IV.
  • Diagnosis of moderate to severe OSA (Apnea-Hypopnea Index \[AHI\] \> 15 events/hour) confirmed by polysomnography.
  • Age ≥ 65 years.
  • Stable clinical condition for at least one month prior to enrollment.
  • Ability to understand and comply with study procedures and provide informed consent.

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Fugou County Minzhong Hospital
Coordinator of this site? Confirm its status
ZhoukouChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.